These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12123109)

  • 1. Recognition of resveratrol by the human estrogen receptor-alpha: a molecular modeling approach to understand its biological actions.
    el-Mowafy AM; Abou-Zeid LA; Edafiogho I
    Med Princ Pract; 2002; 11(2):86-92. PubMed ID: 12123109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential recognition of resveratrol isomers by the human estrogen receptor-alpha: molecular dynamics evidence for stereoselective ligand binding.
    Abou-Zeid LA; El-Mowafy AM
    Chirality; 2004 Mar; 16(3):190-5. PubMed ID: 14770416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulation of the different biological activities of diethylstilbestrol (DES) on estrogen receptor alpha and estrogen-related receptor gamma.
    Nam K; Marshall P; Wolf RM; Cornell W
    Biopolymers; 2003 Jan; 68(1):130-8. PubMed ID: 12579585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of agonist binding to His524 in the estrogen receptor α ligand binding domain.
    Gao L; Tu Y; Ågren H; Eriksson LA
    J Phys Chem B; 2012 Apr; 116(16):4823-30. PubMed ID: 22482773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nongenomic activation of the GC-A enzyme by resveratrol and estradiol downstream from membrane estrogen receptors in human coronary arterial cells.
    El-Mowafy AM; Alkhalaf M; Jaffal SM
    Nutr Metab Cardiovasc Dis; 2007 Sep; 17(7):508-16. PubMed ID: 17134961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha.
    Chakraborty S; Levenson AS; Biswas PK
    BMC Struct Biol; 2013 Oct; 13():27. PubMed ID: 24160181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens.
    Ekena K; Weis KE; Katzenellenbogen JA; Katzenellenbogen BS
    J Biol Chem; 1997 Feb; 272(8):5069-75. PubMed ID: 9030571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular modeling analysis of diethylstilbestrol conformations and their similarity to estradiol-17 beta.
    Wiese TE; Dukes D; Brooks SC
    Steroids; 1995 Dec; 60(12):802-8. PubMed ID: 8650702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
    J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding.
    Zhu BT; Han GZ; Shim JY; Wen Y; Jiang XR
    Endocrinology; 2006 Sep; 147(9):4132-50. PubMed ID: 16728493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
    Duax WL; Swenson DC; Strong PD; Korach KS; McLachlan J; Metzler M
    Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A HOXA10 estrogen response element (ERE) is differentially regulated by 17 beta-estradiol and diethylstilbestrol (DES).
    Akbas GE; Song J; Taylor HS
    J Mol Biol; 2004 Jul; 340(5):1013-23. PubMed ID: 15236964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interactions between estrogen receptor and its ligand studied by the ab initio fragment molecular orbital method.
    Fukuzawa K; Mochizuki Y; Tanaka S; Kitaura K; Nakano T
    J Phys Chem B; 2006 Aug; 110(32):16102-10. PubMed ID: 16898767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
    Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
    Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of estrogen receptor alpha and beta subtypes based on comparative molecular field analysis (CoMFA).
    Xing L; Welsh WJ; Tong W; Perkins R; Sheehan DM
    SAR QSAR Environ Res; 1999; 10(2-3):215-37. PubMed ID: 10491851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial and weak oestrogenicity of the red wine constituent resveratrol: consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects.
    Ashby J; Tinwell H; Pennie W; Brooks AN; Lefevre PA; Beresford N; Sumpter JP
    J Appl Toxicol; 1999; 19(1):39-45. PubMed ID: 9989476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
    Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
    Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
    Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
    Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor (ER) and its messenger ribonucleic acid expression in the genital tract of female mice exposed neonatally to tamoxifen and diethylstilbestrol.
    Sato T; Ohta Y; Okamura H; Hayashi S; Iguchi T
    Anat Rec; 1996 Mar; 244(3):374-85. PubMed ID: 8742702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional model of nonsteroidal estrogen receptor ligand binding/electron topological method.
    Guzel Y; Sivritas K
    Arzneimittelforschung; 2004; 54(6):348-54. PubMed ID: 15281621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.